National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
Rilutek (RY-loo-tek)

 A drug used to treat a nerve disease called amyotrophic lateral sclerosis (ALS). It is also being studied in the treatment of melanoma (a type of skin cancer). Rilutek blocks the release of a substance that melanoma cells need to grow. It is a type of glutamate release inhibitor. Also called riluzole.

Previous Definitions:ribonucleic acid, ribonucleotide reductase inhibitor, Richter syndrome, Richter transformation, rifampin
Next Definitions:riluzole, risedronate, risk factor, risk ratio, ritonavir